简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2023-06-30 14:30 Exscientia Announces Expansion of its Technology Leadership Team
2023-06-29 18:21 AstraZeneca announces $400 million investment in reforestation and biodiversity in support of climate action and human health
2023-06-29 16:52 ZAP Surgical Receives National Medical Products Administration (NMPA) Approval in China
2023-06-29 11:23 Thermo Fisher Scientific Introduces Tumoroid Culture Medium to Accelerate Development of Novel Cancer Therapies
2023-06-29 10:52 Organon Publishes FY2022 ESG Report Showcasing Progress Toward Global Sustainability Goals
2023-06-29 10:36 Microba Commences Phase I Clinical Trial for IBD Therapeutic
2023-06-28 16:24 New Study by KPMG Reveals Alarming Levels of Illicit Cigarettes in the EU, with France Accounting for Almost Half of the Consumption
2023-06-28 15:25 WCD 2023: Galderma to Present Extensive Data Demonstrating Enduring Commitment to Delivering Innovative Solutions in Dermatology
2023-06-27 09:34 Galderma Raises Approximately USD 1 Billion for Newly Issued Shares in a Private Placement Round
2023-06-27 09:14 Vertex Ventures HC Announces $200 Million Fund III to Drive Innovation in Healthcare
2023-06-26 09:57 Jardiance® recommended for the treatment of adults with chronic kidney disease in the EU
2023-06-26 09:49 Pivotal Phase 3 Data Presented at ISTH 2023 Congress Spotlight TAK-755 Prophylaxis for Patients with Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
2023-06-26 09:35 Data shows nearly 19% weight loss in people with overweight or obesity in Boehringer Ingelheim and Zealand Pharma Phase II trial with survodutide (BI 456906)1
2023-06-26 09:16 IPS Strengthens Asia and Pacific Presence with New Managing Director, Matthew Shippey
2023-06-26 09:08 Hospital La Fe Expands Telehealth Program with Masimo W1™ for Preoperative Patients
2023-06-26 08:36 Brainlab and the AO Foundation Collaborate on the Future of Immersive Medical Education and Training
2023-06-25 13:44 Takeda Presents Full Data Set from Phase 3 ADVANCE-CIDP 1 Clinical Trial Investigating HYQVIA® as a Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) at PNS Annual Meeting
2023-06-25 08:49 Ferring Pharmaceuticals appoints new Executive Chairman among key changes to Board of Directors
2023-06-25 08:47 Children’s Hospital Los Angeles: The Best Pediatric Care in California and the Pacific Region of the United States
2023-06-25 08:18 UVDI to Introduce the New UVDI-GO™ UV LED Surface Sanitizer at APIC 2023

Business Wire Weibo

Press Releases

Latest Releases